The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
HH Tang, MQ Zhang, ZC Zhang, C Fan… - Journal of …, 2023 - Taylor & Francis
Objective To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
HH Tang, MQ Zhang, ZC Zhang, C Fan… - Journal of …, 2023 - europepmc.org
Objective To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
HH Tang, MQ Zhang, ZC Zhang, C Fan… - Journal of …, 2023 - dovepress.com
Objective: To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
[HTML][HTML] The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
HH Tang, MQ Zhang, ZC Zhang, C Fan… - Journal of …, 2023 - ncbi.nlm.nih.gov
Objective To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
HH Tang, MQ Zhang, ZC Zhang… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
[引用][C] The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) 1 Inhibitors and Molecular Targeted Therapies for the Treatment of …
H Tang, M Zhang, Z Zhang, C Fan, Y Jin… - Journal of …, 2023 - europepmc.org
Objective: To investigate the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …
(HAIC) combined with PD-(L) 1 inhibitors and molecular targeted therapies (MTT) for …